Arkos Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Arkos Global Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,857	Closed	-$113K	–	133
2026 Q1	$113K	Buy	+1,857	New	+$108K	0.01%	153
2024 Q2	–	Sell	-6,791	Closed	-$368K	–	134
2024 Q1	$368K	Buy	+6,791	New	+$346K	0.06%	91
2021 Q2	–	Sell	-14,988	Closed	-$946K	–	91
2021 Q1	$946K	Sell	14,988 -62	-0.4%	-$3.86K	0.36%	25
2020 Q4	$934K	Sell	15,050 -3,435	-19%	-$211K	0.38%	24
2020 Q3	$1.11M	Sell	18,485 -895	-5%	-$53.9K	0.51%	22
2020 Q2	$1.14M	Buy	19,380 +1,700	+10%	+$102K	0.59%	24
2020 Q1	$985K	Buy	+17,680	New	+$1.08M	0.65%	28

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arkos Global Advisors's BMY Position: Q2 2026 in Review

Arkos Global Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 1,857 shares — an estimated $113K sold.

Arkos Global Advisors first reported a position in BMY in Q1 2020 and held it in 7 quarters. The position peaked at $1.14M in Q2 2020. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Arkos Global Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
Arkos Global Advisors sold 1,857 Bristol-Myers Squibb shares in Q2 2026, an estimated $113K.
Arkos Global Advisors first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 7 quarters.
Arkos Global Advisors's Bristol-Myers Squibb position peaked at $1.14M in Q2 2020.
2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Arkos Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.